Trials / Completed
CompletedNCT04585646
A Two-Week Crossover Dispensing Evaluation Of Orion Daily Wear Soft Contact Lens
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- CooperVision, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of the study is to evaluate the clinical performance of test lens (Orion) in comparison with control lens (Gemini) over a period of two weeks of wear.
Detailed description
The primary objective of the study is to evaluate the clinical performance of test lens (Orion) in comparison with control lens (Gemini) over a period of two weeks of wear. This is a double-masked, randomized, bilateral, two-week crossover, dispensing study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Orion daily disposable contact lens | Subjects will be randomized to wear Orion lens for 2 weeks. |
| DEVICE | Gemini daily disposable contact lens | Subjects will be randomized to wear Gemini lens for 2 weeks. |
Timeline
- Start date
- 2020-09-14
- Primary completion
- 2020-11-30
- Completion
- 2020-12-31
- First posted
- 2020-10-14
- Last updated
- 2022-05-10
- Results posted
- 2022-05-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04585646. Inclusion in this directory is not an endorsement.